MUMBAI, March 13 (Reuters) – A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the…
The post Antibiotic combination marketed by Abbott in India on list of banned drugs appeared first on NASDAQ.